Eli Lilly October 27, 2020 3:40 pm US Officials Cut Short COVID-19 Antibody Trial U.S. regulators have ended one of Eli Lilly’s COVID-19 antibody trials early after data suggested the drug was “unlikely to help” coronavirus patients recover. US & World Videos 1:04 Hunter Biden plans to sue Fox News 23:59 Teen (Girl) Talk with Chelsey Goodan 1:40 Charlie Puth reacts to Taylor Swift's ‘The Tortured Poets Department' name-drop 2:52 Severe weather kills at least 5 as tornadoes rip through Midwest and South 8:39 Gina Rodriguez gushes 0ver motherhood with son Charlie
